|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/09/22 Rubius Therapeutics, Inc. 10-Q 6/30/22 52:4.8M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 896K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K
11: R1 Cover Page HTML 70K
12: R2 Condensed Consolidated Balance Sheets HTML 107K
13: R3 Condensed Consolidated Balance Sheets HTML 34K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 86K
and Comprehensive Loss
15: R5 Condensed Consolidated Statements of Operations HTML 19K
and Comprehensive Loss (Parenthetical)
16: R6 Condensed Consolidated Statements of Cash Flows HTML 97K
17: R7 Condensed Consolidated Statements of Stockholders' HTML 86K
Equity
18: R8 Condensed Consolidated Statements of Stockholders' HTML 17K
Equity (Parenthetical)
19: R9 Nature of the Business and Basis of Presentation HTML 28K
20: R10 Summary of Significant Accounting Policies HTML 33K
21: R11 Investments and Fair Value of Financial Assets and HTML 51K
Liabilities
22: R12 Property, Plant and Equipment, Net HTML 32K
23: R13 Accrued Expenses and Other Current Liabilities HTML 26K
24: R14 Debt HTML 30K
25: R15 Equity HTML 25K
26: R16 Stock-Based Compensation HTML 30K
27: R17 Commitments and Contingencies HTML 24K
28: R18 Net Loss per Share HTML 37K
29: R19 Summary of Significant Accounting Policies HTML 49K
(Policies)
30: R20 Investments and Fair Value of Financial Assets and HTML 52K
Liabilities (Tables)
31: R21 Property, Plant and Equipment, Net (Tables) HTML 30K
32: R22 Accrued Expenses and Other Current Liabilities HTML 25K
(Tables)
33: R23 Debt (Tables) HTML 23K
34: R24 Stock-Based Compensation (Tables) HTML 28K
35: R25 Net Loss per Share (Tables) HTML 39K
36: R26 Nature of the Business and Basis of Presentation HTML 63K
(Details)
37: R27 Summary of Significant Accounting Policies HTML 29K
(Details)
38: R28 Investments and Fair Value of Financial Assets and HTML 59K
Liabilities (Details)
39: R29 Property, Plant and Equipment, Net (Details) HTML 43K
40: R30 Accrued Expenses and Other Current Liabilities HTML 28K
(Details)
41: R31 Debt (Details) HTML 79K
42: R32 Equity (Details) HTML 44K
43: R33 Stock-Based Compensation - Compensation expense HTML 40K
(Details)
44: R34 Commitments and Contingencies - Collaborative HTML 24K
Arrangements and Non-collaborative Arrangement
(Details)
45: R35 Commitments and Contingencies - Defined HTML 24K
Contribution Plan (Details)
46: R36 Net Loss per Share - Weighted Average Shares HTML 49K
(Details)
47: R37 Net Loss per Share - Antidilutive Securities HTML 24K
(Details)
50: XML IDEA XML File -- Filing Summary XML 87K
48: XML XBRL Instance -- ruby-20220630_htm XML 864K
49: EXCEL IDEA Workbook of Financial Reports XLSX 61K
7: EX-101.CAL XBRL Calculations -- ruby-20220630_cal XML 112K
8: EX-101.DEF XBRL Definitions -- ruby-20220630_def XML 244K
9: EX-101.LAB XBRL Labels -- ruby-20220630_lab XML 942K
10: EX-101.PRE XBRL Presentations -- ruby-20220630_pre XML 505K
6: EX-101.SCH XBRL Schema -- ruby-20220630 XSD 87K
51: JSON XBRL Instance as JSON Data -- MetaLinks 256± 354K
52: ZIP XBRL Zipped Folder -- 0001709401-22-000014-xbrl Zip 269K
 | Download this zipped .zip folder |
| Files: | exhibit311certification.htm exhibit312certification.htm exhibit321certification.htm exhibit322certification.htm ruby-20220630.htm ruby-20220630.xsd ruby-20220630_cal.xml ruby-20220630_def.xml ruby-20220630_lab.xml ruby-20220630_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/07/22 Rubius Therapeutics, Inc. 8-K:5,9 7/07/22 11:202K Toppan Merrill/FA 6/08/22 Rubius Therapeutics, Inc. S-3 6:1M Toppan Merrill/FA 7/23/18 Rubius Therapeutics, Inc. 8-K:5,8,9 7/17/18 3:223K Toppan Merrill/FA 7/02/18 Rubius Therapeutics, Inc. S-1/A 7:1M Toppan Merrill-FA |